Schmidt U, Metz K A, Leder L D
Institute of Pathology, University of Essen, Germany.
Br J Haematol. 1995 Jun;90(2):398-403. doi: 10.1111/j.1365-2141.1995.tb05165.x.
T-cell-rich B-cell lymphoma (TCRBCL) is a recently described variant of non-Hodgkin's lymphoma. It may arise de novo or secondary to follicular lymphoma and large B-cell lymphoma. We present here seven cases of TCRBCL to emphasize a peculiar relationship to lymphocyte-predominant Hodgkin's disease. Morphologically, the neoplastic populations of all TCRBCLs, in addition to centroblast-like and immunoblast-like cells, comprised a few L+H-like elements. These neoplastic cells were all regularly scattered in a majority of reactive small T-lymphocytes as well as histiocytes. Moreover, tumour cells of TCRBCL, including the L+H-like elements of TCRBCL, expressed LCA and L26 but did not stain for Leu-M1 and BerH2, as is the case with the Reed-Sternberg cell L+H variant of lymphocyte-predominant Hodgkin's disease. Furthermore, the L26 immunoreaction in one of the cases, which otherwise presented as typical TCRBCL, disclosed a small subcapsular area resembling nodular paragranuloma because some few foci consisting of mature B lymphocytes with occasional L+H-like elements were seen. This also holds true for a second of the TCRBCLs presented that obviously coexisted with recurrent Hodgkin's paragranuloma 10 years after the primary manifestation. These findings indicate a close connection between TCRBCL and lymphocyte-rich Hodgkin's disease, and it may even be speculated as to whether TCRBCL represents merely a phenotypically different manifestation of this Hodgkin's subtype. Although the data presented here will not provide sufficient proof of this hypothesis, it seems clear that the nosology of TCRBCL in the context of current lymphoma classifications requires further elucidation.
富含T细胞的B细胞淋巴瘤(TCRBCL)是一种最近才被描述的非霍奇金淋巴瘤变体。它可能原发出现,也可能继发于滤泡性淋巴瘤和大B细胞淋巴瘤。我们在此呈现7例TCRBCL病例,以强调其与淋巴细胞为主型霍奇金病的特殊关系。形态学上,所有TCRBCL的肿瘤细胞群,除了中心母细胞样和免疫母细胞样细胞外,还包含一些L+H样成分。这些肿瘤细胞均规则地散布于大多数反应性小T淋巴细胞以及组织细胞中。此外,TCRBCL的肿瘤细胞,包括TCRBCL的L+H样成分,表达LCA和L26,但不像淋巴细胞为主型霍奇金病的里德-施特恩伯格细胞L+H变体那样对Leu-M1和BerH2染色。此外,在其中1例原本表现为典型TCRBCL的病例中,L26免疫反应显示出一个类似结节性副肉芽肿的小被膜下区域,因为可见少数由成熟B淋巴细胞及偶尔的L+H样成分组成的病灶。在呈现的另一例TCRBCL病例中也是如此,该病例在初次表现10年后明显与复发性霍奇金副肉芽肿共存。这些发现表明TCRBCL与富含淋巴细胞的霍奇金病之间存在密切联系,甚至可以推测TCRBCL是否仅仅代表这种霍奇金亚型的一种表型不同的表现形式。尽管此处呈现的数据不足以证明这一假说,但显然在当前淋巴瘤分类背景下TCRBCL的疾病分类学需要进一步阐明。